AUTHOR=Jeppesen Troels E. , Simón Marina , Torp Josephine , Knudsen Line B. S. , Leth Julie Maja , Crestey François , Ploug Michael , Jørgensen Jesper T. , Madsen Jacob , Herth Matthias M. , Kjaer Andreas TITLE=Optimization and Evaluation of Al18F Labeling Using a NOTA—or RESCA1-Conjugated AE105 Peptide Antagonist of uPAR JOURNAL=Frontiers in Nuclear Medicine VOLUME=1 YEAR=2021 URL=https://www.frontiersin.org/journals/nuclear-medicine/articles/10.3389/fnume.2021.799533 DOI=10.3389/fnume.2021.799533 ISSN=2673-8880 ABSTRACT=
Fluorine-18 displays almost ideal decay properties for positron emission tomography (PET) and allows for large scale production. As such, simplified methods to radiolabel peptides with fluorine-18 are highly warranted. Chelation of aluminium fluoride-18 toward specific peptides represents one method to achieve this. With the current methods, chelation of aluminium fluoride-18 can be achieved using NOTA-conjugated peptides. However, the heating to 90–100◦C that is required for this chelation approach may be deleterious to the targeting moiety of the probe. Recently, a new chelator, RESCA1, was developed allowing Al18F chelation at room temperature. Here, we optimize the labeling procedure enabling high chelation efficacy of fluoride-18 at 22◦C, even at full batch labeling. The optimized procedure was tested by Al18F-labeling of RESCA1-AE105—a uPAR targeting peptide. NOTA-AE105 was also labeled with Al18F, and the two peptides were compared head-to-head. [18F]AlF-NOTA-AE105 and [18F]AlF-RESCA1-AE105 could be produced in equal radiochemical yields (RCY), radiochemical purities (RCP) and molar activities. Additionally, the two peptides showed comparable binding affinity to uPAR and uptake in cells expressing the uPAR, when evaluated